Pfizer's COVID-19 Vaccine 73% Effective in Kids

In children ages 6 months through 4 years, the Pfizer-BioNTech COVID-19 vaccine proves 73% effective during the time when the Omicron strain was highly prevalent. The vaccine was granted Emergency Use Authorization by the US Food and Drug Administration for this age group on June 17.

Participants in the study received either three 3-0…8g doses of Pfizer-BioNTech vaccine or placebo.

Effectiveness of COVID-19 Vaccine in Kids

"While these results confirm that three 3-0…8g doses of our COVID-19 vaccine provide young children with a high level of protection at a time when the Omicron BA.2 strain was highly prevalent with a favorable safety profile, we are also developing an Omicron BA.4/BA.5-adapted bivalent vaccine in this age group to address these sublineages," said Ugur Sahin, CEO and Co-Founder of BioNTech.

Source-IANS